Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
13 nov. 2023 09h00 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report Third Quarter Financial Results on November 14, 2023
26 oct. 2023 16h22 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Strategic Review to Unlock Shareholder Value
29 août 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) announced today that its Board of Directors is undertaking, in consultation with its financial and legal...
Iridex Reports Second Quarter 2023 Financial Results
10 août 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report Second Quarter Financial Results on August 10, 2023
27 juil. 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Reports First Quarter 2023 Financial Results
11 mai 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report First Quarter Financial Results on May 11, 2023
27 avr. 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
09 mars 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex to Present at the 35th Annual Roth Conference
07 mars 2023 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
02 mars 2023 09h00 HE
|
IRIDEX Corporation
Five Events at Booth #5 Discover the latest surgical techniques and outcomes published by the International MicroPulse TLT Consensus Panel.Watch Dr. Syril Dorairaj’s e-poster on prospective...